 JT, et al. A randomized comparison of doxorubicin alone versus doxorubicin plus cyclophosphamide in the management of advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group study. J Clin Oncol 1994;12:1408-1414.  González-Merlo, J., Ginecología, 8a ed. ©2003 - Pàgina 528per Eduardo González Bosquet - 2003 - 752 pàginesPrevisualització limitada - Sobre aquest llibre
 | Kenneth A. Foon, Hyman B. Muss - 1998 - 306 pàgines
...8:1797-1805. 24. Lentz SS. Brady MF. Major FJ. Reid GC. Soper JT. 1996. High-dose megestrol acetate in advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group Study. J Clin Oncol 14:357-361. 25. Kohorn KI. 1976. Gestagens and endometrial carcinoma. Gynecol Oncol 4:398-41 1. 26.... | |
 | Stan B. Kaye` - 1999 - 804 pàgines
...endometrial carcinoma. Gvnccol Oncol 1994; 55: 47-50. 56. Thigpen JT. Blessing JA. DiSaia PJ et aL A randomized comparison of doxorubicin alone versus...cyclophosphamide in the management of advanced or recurrent endomeinal carcinoma: a Gynecologic Oncology Group study. J Clin Oncol 1994; 12: 1408-14. 57. Podratz... | |
 | Jesús González Bosquet - 2000 - 676 pàgines
...Janeiro, 1 988; 1 3. 1 62. Lentz SS, Brady MF, Major FJ, Reis GC, Soper JT. High-dose megestrol acetate in advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group Study. J Clin Oncol 1996; 14:357-361. 163. Kim YB, Holschneider CH, Ghoso K, Nieberg RK, Montz FJ. Progestin alone as primary... | |
 | 2001 - 196 pàgines
...Oncol 1993 12 : A830. [THIGPEN 1994) Thigpen JT, Blessing JA, DiSaia PJ, Yordan E, Carson LF, EversC. A randomized comparison of doxorubicin alone versus...endometrial carcinoma : a Gynecologic Oncology Group study. / Clin Oncol 1994 ; 12 (7) : 1408-14. [THIGPEN1999I Thigpen JT, Brady MF, Alvarez RD, Adelson MD, Homesley... | |
 | Philip J. DiSaia - 2002 - 742 pàgines
...1980. Thigpen JT, Blessing JA, DiSaia PJ et al: A randomized comparison of doxorubicin alone verus doxorubicin plus cyclophosphamide in the management...carcinoma: A Gynecologic Oncology Group study. J Clin Oncol 12:1408, 1994. Thigpen JT, Blessing JA, Homesley HD et al: Phase II trial of doxorubicin with and without... | |
 | Edward Chu - 2004 - 178 pàgines
...recurrent endometrial cancer: a phase II study. J Clin Oncol 2001;19:4048-4053. 111. Thigpen JT, et al. A randomized comparison of doxorubicin alone versus...carcinoma: a Gynecologic Oncology Group study. J Clin Oncol 1994;12:1408-1414. 112. Deppe G, et al. Treatment of recurrent and metastatic endometrial carcinoma... | |
 | Michael Clinton Perry, Clay M. Anderson, Donald C. Doll - 2004 - 566 pàgines
...Doxorubicin 60 mg/m2 iv day 1 Cyclophosphamide 500 mg/m2 iv day 1 • Repeat every 21 days Thigpen JT, et al. A randomized comparison of doxorubicin alone versus...carcinoma: a Gynecologic Oncology Group study. J Clin Oncol 1994;12:1408-1414. ESOPHAGEAL CANCER Paclitaxel Paclitaxel (Taxol) 250 mg/m2 iv over 24 hours day 1... | |
 | Edward Chu - 2004 - 548 pàgines
...recurrent endometrial cancer: a phase II study. J Clin Onco/2001;19:4048-4053. 111. Thigpen JT, et al. A randomized comparison of doxorubicin alone versus...carcinoma: a Gynecologic Oncology Group study. J Clin Oncol 1994;12:1408-1414. 112. Deppe G, et al. Treatment of recurrent and metastatic endometrial carcinoma... | |
 | Edward Chu, Vincent T. DeVita - 2006 - 572 pàgines
...recurrent endometrial cancer: a phase II study. J Clin Oncol 2001 ; 19:4048-4053. 132. ThigpenJT, et al. A randomized comparison of doxorubicin alone versus...carcinoma: a Gynecologic Oncology Group study. J Clin Oncol 1994;12:1408-1414. 133. Deppe G, et al. Treatment of recurrent and metastatic endometrial carcinoma... | |
 | Debra S. Prescher-Hughes, Cynthia J. Alkhoudairy - 2007 - 710 pàgines
...recurrent endometrial cancer: a phase II study. J Clin Oncol. 2001;19:4048-4053. 144. Thigpen JT, et al. A randomized comparison of doxorubicin alone versus...a Gynecologic Oncology Group study. J Clin Oncol. 1994:12:1408-1414. 145. Deppe G, et al. Treatment of recurrent and metastatic endometrial carcinoma... | |
| |
